Invitae: Robert Dickey, Christine Gorjanc
Invitae named Robert Dickey as interim CFO, effective immediately. Dickey previously worked at Lehman Brothers, conducting mergers and acquisitions and capital markets transactions. In addition to his new position at Invitae, he serves as a member of the board of directors at AngioGenex, SFA Therapeutics, and GSNO Therapeutics. Former interim CFO Christine Gorjanc will return to her prior role as chair of the audit committee and a member of the compensation committee of Invitae's board. Gorjanc and Dickey will both work with the executive leadership team to ensure a smooth transition, while Gorjanc continues to assist the company in searching for a permanent CFO.